Quoin Pharmaceuticals Ltd - יחס שווי כולל של החברה להכנסות QNRX

The enterprise value-to-revenue ratio displayed by the GURU.Markets system helps assess the strategy of Quoin Pharmaceuticals (QNRX) in developing unique treatments for fatal genetic skin pathologies. 0.00 captures the magnitude of this parameter while the company spends working capital on pre-commercial tests. High loyalty among the staff of biochemists and dermatologists ensures success in treating rare dermatological diseases.
Quoin Pharmaceuticals Ltd. - פילוחים אנליטיים ומדדי מפתח (QNRX)

The scale of drug development for rare dermatological pathologies under conditions of geopolitical neutrality makes the EV-to-revenue ratio a key indicator of the business's objective value. This metric compares the total market price of assets with sales volume, excluding the impact of debt load, which allows investors to assess the fundamental maturity of Quoin Pharmaceuticals (QNRX) and the stability of its market capitalization.